SCHEMBL8285201

SCHEMBL8285201

Cc1nc2c(cc1/C=C/c1ccccc1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
TP53 P04637 1/20 0.40
PDE11A Q9HCR9 1/20 0.39
ATP4A P20648 2/20 0.39
ATP4B P51164 2/20 0.39
ALDH1A2 O94788 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
GAA P10253 2/20 0.36
MEN1 O00255 2/20 0.36
POLB P06746 2/20 0.36
KMT2A Q03164 2/20 0.36
GFER P55789 1/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5871760 0.87 HDAC1 (0.39) TP53PDE11AHDAC1HDAC8HDAC6
SCHEMBL5871748 0.87 HDAC1 (0.39) TP53PDE11AHDAC1HDAC8HDAC6
SCHEMBL8285212 0.86 HDAC1 (0.40) LMNATP53PDE11AALDH1A1HDAC1
SCHEMBL8285204 0.85 HDAC1 (0.38) TP53PDE11AHDAC1HDAC8HDAC6
SCHEMBL8287362 0.85 HDAC1 (0.41) TP53PDE11AHDAC1HDAC8HDAC6
SCHEMBL5872140 0.85 HDAC1 (0.37) LMNATP53PDE11AALDH1A1HDAC1
SCHEMBL5872137 0.85 HDAC1 (0.37) LMNATP53PDE11AALDH1A1HDAC1
SCHEMBL5871894 0.84 PDE11A (0.43) LMNAPDE11AALDH1A1GAAMEN1
SCHEMBL8287126 0.84 HDAC1 (0.37) TP53PDE11AHDAC1HDAC8HDAC6
SCHEMBL8287451 0.83 PDE11A (0.42) LMNAPDE11AALDH1A1GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed